Current Opinion in Urology

Article	Citations
Editorial introductions	75
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies	52
Research frontiers in urology	51
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects	47
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker	28
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis	27
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma	23
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update	23
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments	20
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology	20
The role of innovations in advancing urologic oncologic patient care	20
Tissue-based gene expression testing in localized prostate cancer	19
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder	17
Editorial introductions	17
Editorial introductions	16
RNA-based urinary assays for non-muscle invasive bladder cancer	15
Testicular cancer with small metastatic burden: optimal approach in 2024	15
Editorial introductions	15
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer	14
Sustainable practices in hospital and operating theaters	13
Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?	13
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations	13
Optimizing clinical risk stratification of localized prostate cancer	12
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma	12
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature	11

Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects	11
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology	11
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer	11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty	11
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature	11
Endourology at the crossroads of innovation: technology, artificial intelligence and patient-focused care – an EAU endourology perspective	11
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions	11
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors	10
Metabolic syndrome, obesity and cancer risk	10
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging	10
Is there a role for metastasis-directed therapy in bladder cancer?	10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints	10
Utility of augmented reality in endoscopic surgery for stones: European Association of Urology endourology up-to-date review	9
Management of vaginoplasty canal complications	9
Personalised medicine in urothelial carcinoma: where do we stand and what is the way to go?	9
Brief update of the new WHO classification for urothelial carcinoma	9
Histologic subtypes of urothelial carcinoma: an update	9
The role of surgery for locally advanced urothelial cancers	9
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?	9
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities	9
Advances in laser pulse modulations	9
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer	9
Preoperative geriatric assessment of urological patients: a narrative review	9
Update on classification of oncocytic neoplasms of the kidney	9
Decoding germ cell tumours for clinicians	8
Toxicities of taxane-based chemotherapy in prostate cancer	8
Patient-reported outcomes in genital gender-affirming surgery	7
Preoperative patient optimization for endourological procedures: the current best clinical practice	7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance	7
MR-guided radiotherapy for prostate cancer: an inevitable transition?	7
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review	7
Sarcomatoid urothelial carcinoma: advances and challenges	7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors	7
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes	7
AI-powered radiomics: revolutionizing detection of urologic malignancies	7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis	7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer	7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies	7
Editorial introductions	7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma	7
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma	6
Use of genomic markers to improve epidemiologic and clinical research in urology	6
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature	6
The carbon footprint of modern imaging	6
Advanced sperm tests and impact on clinical male factor management	6
Medical therapy for male infertility	6
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer	6
Percutaneous management of caliceal diverticula: a narrative review	6
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis	6
Liquid biomarkers in prostate cancer: recent advancements and future directions	6

Open versus robot-assisted surgery in reconstructive urology: lessons from vesicourethral anastomotic stenosis and radical cystectomy	6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?	6
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis	6
Inflammation and kidney stones: cause and effect?	6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer	6
Graft and flap choices in anterior urethroplasty: oral mucosa and beyond	5
Metabolic evaluation: is there really a future?	5
Preclinical models for bladder cancer therapy research	5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses	5
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters	5
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?	5
Editorial introductions	5
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology	5
Genetics of testicular cancer: a review	5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy	5
Surgical management of testicular cancer with limited retroperitoneal disease	5
Role of cytoreductive surgery in the era of immunotherapy	5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era	5
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis	5
Novel intravesical delivery systems for nonmuscle invasive bladder cancer	5
Editorial: Future of kidney stone management	5
The use of MRI in urothelial carcinoma	5
The environmental impacts of anesthesia	5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population	5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers	5
Organ storage in renal transplantation	5
Pelvic pain syndromes	5
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review	5
Integration of novel artificial intelligence tools in pediatric urologic practice	5
New technologies for nephron-sparing surgery in upper urinary tract cancers	5
Overlooked and underserved: how healthcare fails men in the pursuit of equity	5
Editorial introductions	4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis	4
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers	4
Editorial introductions	4
Medical management of male infertility: now and future	4
Angiomyolipoma/PEComa: the past, the present…and back to the future	4
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?	4
Endo-technology and its future: where are we heading?	4
Advances in ureteral stent technology	4
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherap	4
Nectin-4 in bladder cancer: biology and predictive biomarker potential	4
Chronic pelvic pain; more than just the bladder	4
Where are we in 2024 in the development of materials for surgical treatment of pelvic organ prolapse and stress urinary incontinence?	4
Reducing financial toxicity in bladder cancer care	4
Transperineal vs. transrectal biopsy to reduce postinterventional sepsis	4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models	4
Leveraging behavioral modification technology for the prevention of kidney stones	4
Urachal cancer: a clinical, diagnostic, and therapeutic update	4
Bladder diverticula management – conservative and surgical outcomes: a narrative review from EAU endourology	4
Small tools, big impact and redefining endourology: the paradigm shift of ureteroscopy for large stones and percutaneous nephrolithotomy for small stones – a literature review	4
The spread of retzius-sparing robotic prostatectomy: an update after 10 years	4
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement	4
Pembrolizumab in mCRPC – Combination therapies as breakthrough to success?	3
Optimal systemic therapy in men with low-volume prostate cancer	3
Editorial introduction	3
En bloc resection of large bladder tumor: is it feasible and reasonable?	3
Artificial intelligence in muscle-invasive bladder cancer: opportunities, challenges, and clinical impact	3
Polygenic risk score in prostate cancer	3
Radical cystectomy and women's sexual health – can we do better?	3
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine	3
Radioguided surgery for lymph node metastases in prostate cancer	3
Trends in outpatient versus inpatient urologic surgery at a university academic medical center	3
Metastasectomy in renal cell carcinoma: where are we now?	3
Biomarkers and testing in pathology	3
Metastasis-directed treatment in kidney cancer	3
Burst wave lithotripsy: insights on effectiveness and safety	3
Urinary continence in high-risk prostate cancer after robot-assisted radical prostatectomy	3
Editorial: Metastatic prostate cancer: a wealth of data to put into practice	3
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?	3
The role of cytoreductive nephrectomy in the immuno-oncological therapy era	3
Drug instillation in the management of urinary tract urothelial carcinoma	3
Editorial introductions	3
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions	3
A narrative review on the performance and outcomes of penile and scrotal surgery in the ambulatory setting	3
Urological impact of flozins (SGLT2 inhibitors): an EAU Endourology review of risks, side effects and clinical considerations	3
The quality of life value in uro-oncological patients	3
Extended pelvic lymph node dissection in muscle invasive bladder cancer	3
The future of laser technology in kidney stones	3
Navigating bladder preservation in Bacillus Calmette–Guérin-unresponsive disease: how much risk is too much?	3

Simulation training in urology	3
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology	3
Recent advancements in personalized management of prostate cancer biochemical recurrence after radical prostatectomy	3
Review of second-generation androgen receptor inhibitor therapies and their role in prostate cancer management	3
Impact of lifestyle and environmental factors on fertility	3
Diagnostic evaluation for adrenal tumors – What does the urologist need to know about endocrine metabolic work up?	3
The role of suction devices in enhancing outcomes of retrograde intrarenal surgery: a narrative review by the YAU urolithiasis and section of EAU endourology	3
Stone metrics: is stone volume the new king?	3
Tumour microenvironment and focal therapy for prostate cancer	3
The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma	2
VISION, TheraP, LuTectomy and beyond – is there a role for lutetium therapy in biochemical recurrence?	2
Renal cell carcinoma with inferior vena cava thrombus: did we make progress in oncologic outcomes and complications?	2
Genetics of male infertility	2
The future of urothelial carcinoma: a 2024–2025 update of early-phase trials of novel therapeutic agents	2
Emerging strategies: conservative management of upper tract urothelial carcinoma	2
Molecular research in bladder cancer	2
Bridging the gap: health equity in women's urologic care across rural settings	2
Measuring quality of life in patients with kidney stone disease: is it the future in endourology?	2
Should we redefine the Phoenix criteria for biochemical recurrence after primary radiotherapy?	2
Electromagnetic-guided puncture: a tool or a tale?	2
Salvage radical prostatectomy	2
Robotic-assisted retroperitoneal lymph node dissection for testicular cancer	2
Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology	2
Techniques and outcomes of percutaneous tumour ablation for small renal masses	2
Thulium fiber laser in endourology: current clinical evidence	2
Transurethral resection of bladder cancer with or without fluorescence	2
Past, present and future of genomics for kidney stone disease	2
Organ-sparing treatment for T1 and T2 penile cancer: an updated literature review	2
Advancing men's health: insights and innovations	2
Recent advances in urologic surgical pathology and molecular biomarker testing	2
Current developments in prehabilitation in urologic oncology	2
Updates on the use of neuromodulation in geriatric patients	2
Assessing the ripple effects of natural disasters on healthcare systems: a narrative review	2
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023	2
Editorial introductions	2
Demystifying machine learning in endourology – understanding models, applications, and clinical impact: a review from EAU endourology	2
Novel germline mutations for active surveillance and imaging strategies in prostate cancer	2
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer	2
Intraoperative assessment of surgical margins during radical prostatectomy: advances and challenges	2
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer	2
Experimental and translational models in urethral stricture research	2
Editorial: genetics in urology	2
The advance of artificial intelligence in outpatient urology: current applications and future directions	2
Imaging in stone diagnosis and surgical planning	2
Association between male infertility and prostate cancer: a systematic review and meta-analysis: erratum	2
Mitigating infections in implantable urological continence devices: risks, challenges, solutions, and future innovations. A comprehensive literature review	2
Non-invasive central nervous system stimulation to improve bladder and pelvic floor function in the aging population	2
Artificial urinary sphincter: recent developments and the way forward	2
Advancements in radiotherapy for genitourinary cancers	2
Evaluation and management of male genital tract infections in the setting of male infertility: an updated review	2
Editorial introductions	2
Prevention and management of urinary tract infections after cystectomy	2
Current perspectives and controversies in urothelial carcinoma: from treatment expansion to decision complexity	2
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?	2
Bacillus Calmette-Guérin unresponsive NMIBC: novel therapies and concepts	2
ChatGPT in urology practice: revolutionizing efficiency and patient care with generative artificial intelligence	2
The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting	2
Future directions in transfeminine genital gender-affirming surgery: tissue substitutes and transplant	2
Editorial introduction	2
Climate change and urologic care: a challenge for patients and providers	2
Adrenal functional imaging – which marker for which indication?	2
Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence	2
Micropapillary bladder cancer: an evolving biology	2